The adverse effects of cannabinoids: implications for use of medical marijuana

Degenhardt, Louisa; Hall, Wayne D.
June 2008
CMAJ: Canadian Medical Association Journal;6/17/2008, Vol. 178 Issue 13, p1685
Academic Journal
The authors reflects on the impact of using cannabis for medical purposes. The authors infers that the current review of evidence from clinical trials of cannabinoids and cannabis extracts for medical indications suggests that the adverse effects of their short-term use are modest. The authors suggests that research is needed to evaluate the adverse effects of longterm use of medical cannabinoids, such as for the treatment of multiple sclerosis and chronic pain.


Related Articles

  • A sane solution to an irrational standoff. BOSTWICK, J. MICHAEL // Minnesota Medicine;Apr2014, Vol. 97 Issue 4, p36 

    The author discusses the designation of cannabis as a Schedule 1 drug indicating it had no medical value and a high risk of abuse. He notes how current medical marijuana products challenges ideas on what constitutes a legitimate medication He indicates that rescheduling cannabis as Schedule 2...

  • Legalising medical cannabis in Australia. Smith, Hamish R. // Australian Medical Student Journal;Jul2013, Vol. 4 Issue 1, p56 

    The article discusses the medico-legal arguments for and against the use of cannabis as a psychotropic drug in Australia. The human body reacts with cannabis through the delta-9-tetrahydroxcanabinol (THC), cannabinol and cannabidiol (CBD). It is considered illegal to use these psychotropic...

  • Adverse effects of medical cannabinoids: a systematic review. Tongtong Wang; Collet, Jean-Paul; Shapiro, Stan; Ware, Mark A. // CMAJ: Canadian Medical Association Journal;6/17/2008, Vol. 178 Issue 13, p1669 

    Background: The therapeutic use of cannabis and cannabis-based medicines raises safety concerns for patients, clinicians, policy-makers, insurers, researchers and regulators. Although the efficacy of cannabinoids is being increasingly demonstrated in randomized controlled trials, most safety...

  • Can Medical Marijuana Help Pediatric Patients? Lippman, Helen // Neurology Reviews;Dec2014, Vol. 22 Issue 12, p1 

    The article focuses on prospects of using marijuana for the treatment of childhood epilepsy, movement disorders, and multiple sclerosis (MS) based on reviewing studies from 1948 to 2013. It mentions views of Francis M. Filloux, Pediatric Neurology Division's Chief at the University of Utah...

  • Alaska goes to pot.  // Drug Topics;3/15/99, Vol. 143 Issue 6, p7 

    Reports that medicinal marijuana has been made legal in the state of Alaska. Requirement for patients to have a recommendation from a physician before using marijuana for therapeutic purposes.

  • Israeli innovation extends to weed. Shapiro, Marc // Washington Jewish Week;3/19/2015, Vol. 51 Issue 12, p8 

    The article talks about Israel being a leader in the medicinal marijuana industry, it's production of vaporizers, and promotion of medicinal cannabis.

  • Update. Streisand, Betsy // U.S. News & World Report;03/30/98, Vol. 124 Issue 12, p4 

    Looks at the United States government's intention of taking six Northern California cannabis clubs to court. The government argument that the clubs should be permanently closed down for selling a controlled substance; Impact of a ruling against the clubs; Provisions of California Proposition...

  • THE INTEGRATIVE MD ON... Are there really medical benefits from marijuana? WEIL, ANDREW // Prevention;Oct2015, Vol. 67 Issue 10, p127 

    The author tells that cannabinoids, the active compound in marijuana has medical use and many states in the United States have legalized medical marijuana though federal government has not approved the same.

  • 5 things to know when buying medical cannabis.  // Filipino Post;1/15/2015, p10 

    No abstract available.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics